Overview

Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of golimumab in Chinese patients with ankylosing spondylitis
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Antibodies, Monoclonal
Golimumab